Related Experiment Video
Updated: Jul 16, 2025

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Osteosarcoma's genetic landscape painted by genes' mutations.
Wiktoria Urban1, Dagmara Krzystańska1, Michał Piekarz2
1Department of Cell Biology, Poznan University of Medical Sciences, Poznań, Poland.
This study identifies frequently mutated genes in osteosarcoma (OS), a common bone cancer. Analyzing these genetic mutations may help predict OS development and track disease progression.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Osteosarcoma (OS) is a prevalent primary bone tumor with largely unknown direct pathogenesis.
- Gene mutations are recognized as key contributors to OS development.
Purpose of the Study:
- To identify frequently mutated genes in OS.
- To propose candidate genes for use as cancer markers in OS.
Main Methods:
- Utilized the COSMIC Catalogue to select the twenty most frequently mutated genes in OS.
- Classified selected genes into categories: tumor suppressor, proto-oncogene, epigenetic/post-translational modification-related, and cell growth/survival regulators.
Main Results:
- Compiled an updated summary of the genetic landscape of OS.
- Identified specific genes within each functional category, including TP53, RB1, GNAS, BRAF, SMARCA4, ARID1A, EGFR, and MED12.
Conclusions:
- Confirmed the role of these genes in cancerogenesis through literature review.
- Examining mutations in these selected genes may aid in identifying patient predisposition, monitoring disease progression, and establishing prognosis for OS.
- Further research is necessary to fully elucidate the pathogenesis of OS.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

